PAGB updates summary of MHRA’s post-Brexit guidance for medicines

This week, we released our updated summary of MHRA’s regulatory guidance for medicines. This substantial update follows the numerous changes to guidance since implementation of the Windsor Framework in January 2025.

This week, we released our updated summary of MHRA’s regulatory guidance for medicines. This substantial update follows the numerous changes to guidance since implementation of the Windsor Framework in January 2025, concentrating on the key guidance relevant to OTC medicines.

PAGB’s summary brings together information from the various guidance pages on the MHRA website, clarifications from MHRA where relevant, and contains links to where more detailed information can be found. Members will find this a useful overview for licencing, maintaining and supplying of medicinal products throughout the UK.

Members can read the full guidance here.

Please note that you will need to be logged in to the members area to view this.

Related news

Self-Care Week blog post from Mark Burdon

Our final blog post this Self-Care Week delves into the pivotal role that pharmacies are playing in the Government’s 10 Year Health Plan. Mark explores the impact of Pharmacy First paving the way, the current challenges that the Government should be prioritising and how digital tools can bring support pharmacists as they widen access to self-care and help streamline patient journeys.

Self-Care Week blog post from Mark Burdon
View all